study addresses

race/ethnicity, mistreatment, and lack of operative autonomy—which the authors describe in their abstract as a proxy for loss of meaning in work— moderate-to-severe pain (odds ratio [OR] 2.52, 95% confidence interval [CI] 1.48–4.26) and using physiotherapy as pain management (OR 3.06, 95% CI 1.02–9.14) were determined to be risk factors for burnout.

In light of these findings, the presenter suggested in his conclusion that programs “should provide ergonomic education and adjuncts, such as posture awareness and microbreaks during surgery, early and throughout training”.

Pillado presented this work on behalf of senior author Dawn M. Coleman, MD, chief of the division of vascular and endovascular surgery at Duke University Medical Center in Durham, North Carolina, and the Vascular Surgery

SECOND trial steering committee.

Jocelyn Hudson

Asymptomatic Carotid Patients

Alessandro Gregio, MD, a vascular surgery trainee at the University of Bologna in Bologna, Italy, presented midterm results from the Carotid asymptomatic stenosis observational study during the first of two SVS-VESS (Vascular and Endovascular Surgery Society) Scientific Sessions yesterday afternoon.

“Whether to intervene or to follow [asymptomatic] patients with best medical therapy is an ongoing matter of debate,” said Gregio, noting that he and colleagues performed a prospective observational cohort study to add data to the discussion. Out of 366 patients enrolled in the study, 306 completed follow-up.

Gregio, who was presenting the study results on behalf of senior author Mauro Gargiulo, MD, and colleagues, concluded that the 48-month risk of ipsilateral transient ischemic attack or stroke was 6% in a real-world scenario. He added that adherence to best medical therapy is high in this population, and also that plaque progression and contralateral stenosis are risk factors for neurological events during follow-up.

The researchers will follow patients out to five years, the presenter noted.

VASCULAR ONCOLOGY ONCO-VASCULAR SESSION SET TO OFFER

In

Surgery

RANDALL DEMARTINO, MD, IS DIVISION CHAIR OF VASCULAR AND Endovascular Surgery at the Mayo Clinic in Rochester, Minnesota, and a co-moderator of a session dedicated to onco-vascular surgery, taking place today from 3:30–5 p.m. in National Harbor 12/13. A series of presentations will feature case reviews as well as discussion of how to achieve the best outcomes in vascular reconstruction for oncology patients. DeMartino previewed the session for VS@VAM ahead of time.

“The goal of the session is to describe the landscape of cases that aren’t as typical in vascular training,” DeMartino begins, outlining how in recent years, vascular surgeons have been taking on increasing numbers of cases from oncology colleagues for tumors involving vascular structures and performing reconstruction post-resection. “We want to be able to help” in affording patients the better chance at survival that resection can provide, he emphasizes, while noting how this is a “new” field for many vascular surgeons. The growing case numbers he and other vascular surgeons have been seeing is what prompted his interest in holding the session at this year’s VAM, DeMartino adds.

There is a significant need for multidisciplinary collaboration in order to deal with these complex cancer cases, he continues, citing urology and orthopedics as among the departments he works with. “We find ourselves [working] all over the body,” he summarizes, pointing out that vascular surgeons “are the experts in helping the patients maintain limb or organ function through the vasculature.”

The session will cover multidisciplinary collaboration and the importance of good communication among the specialties involved in a particular case; which imaging modalities to use; how to approach patients who have had previous surgeries or whose tumor has been irradiated; how to set up and prepare mentally for emergency cases; and how best to follow up with different patients.